Sponsors (6)
The bill expands 340B discounts to rural emergency hospitals to lower drug costs and bolster safety‑net services for rural and low‑income patients, but it risks reduced manufacturer revenue, greater program complexity, and uncertain redistribution of savings away from direct patient care.
Rural emergency hospitals (especially public and nonprofit) can buy outpatient drugs at 340B discounted prices, lowering pharmacy acquisition costs for those hospitals.
Lower drug acquisition costs for these hospitals make medicines and services more affordable, improving access to care for rural and low‑income patients.
Public and nonprofit rural emergency hospitals that serve low‑income, non‑Medicare patients gain a stable financing tool to support safety‑net services.
Drug manufacturers may see reduced revenue as more hospitals join 340B, which could push manufacturers to raise prices elsewhere or limit drug availability.
If hospitals redirect 340B savings away from patient care (for example to general operating budgets), the intended patient benefits may be smaller or uneven.
Expanding 340B eligibility increases program complexity and oversight needs for HHS and other agencies, likely requiring more administrative resources at federal and state/local levels.
Based on analysis of 2 sections of legislative text.
Introduced January 3, 2025 by John Bergman · Last progress January 3, 2025
Adds certain rural emergency hospitals to the list of entities eligible for the federal 340B drug discount program. Eligible facilities are rural emergency hospitals that are state or local government owned/operated, nonprofit corporations granted governmental powers, or private nonprofit hospitals that contract with a state or local government to serve low-income, non‑Medicare/non‑Medicaid patients.